Nociceptive Signals Induce Trafficking of TRPA1 to the Plasma Membrane  by Schmidt, Manuela et al.
Neuron
ArticleNociceptive Signals Induce Trafficking
of TRPA1 to the Plasma Membrane
Manuela Schmidt,1 Adrienne E. Dubin,1 Matt J. Petrus,2 Taryn J. Earley,1 and Ardem Patapoutian1,2,*
1Department of Cell Biology, The Scripps Research Institute, La Jolla, CA 92037, USA
2Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121, USA
*Correspondence: apatapou@gnf.org
DOI 10.1016/j.neuron.2009.09.030SUMMARY
Transient receptor potential A1 (TRPA1) ion channel
senses a variety of noxious stimuli and is involved
in nociception. Many TRPA1 agonists covalently
modify the channel, which can lead to desensitiza-
tion. The fate of modified TRPA1 and the mechanism
of preserving its response to subsequent stimuli
are not understood. Moreover, inflammatory signals
sensitize TRPA1 by involving protein kinase A (PKA)
andphospholipaseC (PLC) through unknownmeans.
We show that TRPA1-mediated nocifensive behavior
can be sensitized in vivo via PKA/PLC signaling and
by activating TRPA1 with the ligand mustard oil
(MO). Interestingly, both stimuli increased TRPA1
membrane levels in vitro. Tetanus toxin attenuated
the response to the second of two pulses of MO in
neurons, suggesting that vesicle fusion increases
functional surface TRPA1. Capacitance recordings
suggest that MO can induce exocytosis. We propose
that TRPA1 translocation to the membrane might
represent one of the mechanisms controlling TRPA1
functionality upon acute activation or inflammatory
signals.
INTRODUCTION
TRPA1 is an essential transduction ion channel expressed in
sensory neurons of the dorsal root ganglia (DRG) and trigeminal
ganglia (TG), and is involved in acute and inflammatory pain
(Bandell et al., 2004; Bautista et al., 2006; Katsura et al., 2006;
Kwan et al., 2006; Macpherson et al., 2007; Obata et al., 2005;
Story et al., 2003). As a sensor of chemical damage, TRPA1
can be activated by surprisingly diverse electrophilic and non-
electrophilic chemicals. Electrophilic TRPA1 agonists, like allyl-
isothiocyanate (mustard oil [MO]) and cinnamaldehyde, do not
share structural similarity, but exert their activity through cova-
lent modification of cysteine residues within the intracellular
N terminus of TRPA1 (Hinman et al., 2006; Macpherson et al.,
2007). Given that the half-life of isothiocyanate-cysteine
complexes is in the order of 1 hr, this unique mode of activation
imposes a substantial problem to signal termination, because
the response of TRPA1 to electrophilic agonists would be pre-
dicted to last far beyond the stimulus duration (Conaway et al.,498 Neuron 64, 498–509, November 25, 2009 ª2009 Elsevier Inc.2001). Desensitization (tachyphylaxis) of TRPA1 in response to
chemical agonists offers a short-term solution to this problem
(Wang et al., 2008b). However, maintenance of the sensitivity
of nociceptive neurons to subsequent stimulation by TRPA1
agonists is critical, and how this is accomplished is not known.
In addition to its role in acute nociception, TRPA1 has been
implicated in sensing inflammatory signals. Tissue damage and
inflammation cause physiological changes to sensory neurons
involving reduced threshold and enhanced responsiveness
(peripheral sensitization). A variety of signals including chemo-
kines, growth factors, kinins, proteases, and various kinases
have been implicated in inducing peripheral sensitization (Hucho
and Levine, 2007). The resulting hyperalgesia (exaggerated pain
response) and allodynia (pain response to innocuous stimuli) is
thought to contribute to the etiology of chronic pain syndromes.
Recently, signaling pathways leading to TRPA1 sensitization or
potentiation have been reported (Dai et al., 2007; Wang et al.,
2008a). These studies suggest sensitization of TRPA1-mediated
nocifensive behavior upon injection of bradykinin and activators
of proteinase-activated receptor (PAR) 2, respectively. Further-
more, in vitro, electrophysiological recordings on DRG neurons
imply the involvement of protein kinase A (PKA) and phospholi-
pase C (PLC) signaling in potentiating MO-induced TRPA1
currents (Dai et al., 2007; Wang et al., 2008a); however, the
molecular mechanisms remain to be elucidated.
The function of a variety of ion channels and receptors is
known to be regulated by their constitutive or regulated traf-
ficking. In the central nervous system, the tight regulation of
AMPA receptor cycling between plasmamembrane and intracel-
lular compartments underlies synaptic plasticity (Malenka, 2003;
Shepherd and Huganir, 2007). Moreover, there is ample
evidence that long-lasting modulation of nociceptive receptor
surface expression is associated with differentially altered traf-
ficking. For example, sensitization of trigeminal neurons by calci-
tonin gene-related peptide (CGRP) increases currents through
ATP-activated purinergic P2X3 receptors by enhancing their
translocation to the membrane (Fabbretti et al., 2006). Similarly,
sensitization of TRPV1 channels by nerve growth factor (NGF)
partly involves TRPV1 membrane trafficking (Ji et al., 2002;
Zhang et al., 2005). On the other hand, several studies have
shown that cannabinoid-induced internalization of type 1 canna-
binoid receptor (CB1) contributes to tolerance (Tappe-Theodor
et al., 2007). A different mechanism seems to account for
morphine-induced tolerance, where receptor internalization
and recycling to the cell surface is required to render the recep-
tors competent after morphine binding (Zhang et al., 2006).
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Regulation of TRPA1 Levels at the Plasma MembraneFigure 1. TRPA1-Mediated Pain Responses Can
Be Sensitized In Vivo
(A) C57Bl6 male mice were injected with vehicle (12%
EtOH) or FSK and m-3m3FBS (1 mM each) followed by
an injection of MO (1 mM). Plots show quantitation of
the response duration of acute nocifensive behavior to
MO during 5 min after vehicle (18.0 ± 4.7 s) and FSK and
m-3m3FBS (39.1 ± 7.5 s) preinjection in the paw (n = 12
mice for vehicle and n = 11 mice for FSK and
m-3m3FBS). p = 0.0338, Mann-Whitney test.
(B) C57Bl6 male mice were injected with vehicle (12%
EtOH), FSK (6 mM), or m-3m3FBS (1.2 mM) followed by
an injection of MO (1 mM). Plots show quantitation of the
response duration of acute nocifensive behavior to MO
during 5 min after vehicle (13.6 ± 5.7 s), FSK (51.9 ± 11.4 s), or m-3m3FBS (28.8 ± 8.7 s) preinjection in the paw (n = 12 mice for each condition). FSK sensitizes
TRPA1-mediated responses compared with vehicle. **p < 0.01; one-way ANOVA followed by Dunnett’s Multiple Comparison Test.
(C) C57Bl6male mice were injected withMO (10mM), and the duration of acute nocifensive behavior wasmeasured for each group for 5min (5.0 ± 1.3 s and 5.6 ±
1.2 s; n = 8 mice for each group). Subsequently mice were either injected with MO (10 mM) or vehicle (1% DMSO in PBS) and again, acute nocifensive behavior
was assessed for 5 min. Plots show quantitation of the response duration to either injection (n = 8 mice for each group). Responses to a second MO injection
(86.1 ± 13.8 s) were significantly enhanced compared with vehicle injection (22.0 ± 11.0 s) or single injection of 20 mMMO (12.6 ± 3.5 s; n = 8 mice). ***p < 0.001,
one-way ANOVA followed by Bonferroni’s multiple comparison test.
Error bars = SEM.Similar mechanisms might account for the unique activation
characteristics of electrophilic agonists on TRPA1 and TRPA1
sensitization. Despite the importance of TRPA1 in transducing
noxious stimuli, and numerous studies describing various mech-
anisms of TRPA1 activation, little is known about TRPA1
membrane trafficking and the regulation of channel availability
at the cell surface.
In this study, we set out to address the regulation of TRPA1
membrane levels using a combination of immunostaining, live-
labeling, calcium imaging and electrophysiology. Our data
suggest that different stimuli converge to recruit functional
TRPA1channels to theplasmamembrane, uncoveringapotential
molecular mechanism for the involvement of TRPA1 in sensing
acute tissue damage and in peripheral sensitization.
RESULTS
TRPA1-Mediated Pain Responses Are Sensitized In Vivo
The role of TRPA1 in sensing acute damage is well established.
However, less is known about its role in inflammation. Recently,
it has been demonstrated that PKA and PLC signaling pathways
sensitize MO-induced TRPA1 currents in vitro (Dai et al., 2007;
Wang et al., 2008a). We initially tested whether the TRPA1 sensi-
tization observed in vitro is of physiological relevance in vivo.
Injection of a combination of forskolin (FSK, which activates
adenylyl cyclase) and N-(3-Trifluoromethylphenyl)-2,4,6 trime-
thylbenzenesulfonamide (m-3m3FBS, an activator of PLC-
signaling) into the left hindpaw of mice did not evoke obvious
nocifensive behaviors. Ten minutes later, a relatively low amount
of MO (1 mM) was injected, and animals were observed for pain
behaviors (nocifensive response). Interestingly, the duration of
MO-induced nocifensive responses was significantly increased
upon pretreatment with FSK and m-3m3FBS compared with
vehicle (Figure 1A). We then tested whether activation of either
PKA or PLC signaling sensitized TRPA1 channels in vivo. Indeed,
pretreatment with higher concentrations of FSK sensitized noci-
fensive responses toMO. Interestingly, FSK at this concentrationdid not affect thermal hyperalgesia, arguing for some specificity
(data not shown). We also assayed m-3m3FBS alone and
observed a trend toward sensitization, but no statistical signifi-
cance (Figure 1B). We were not able to increase the concentra-
tion of m-3m3FBS due to unspecific effects of the vehicle (EtOH)
at higher concentrations (>12% EtOH caused pain and could
not be used in our assay). Our results suggest that sensitization
by PKA and PLC activators is functionally relevant for TRPA1
physiology.
In a related set of experiments, the in vivo consequence of
repeated MO application was tested. Under some recording
conditions (e.g., whole cell in presence of calcium), MO causes
severe tachyphylaxis of TRPA1, such that repeated stimuli evoke
highly diminished responses (Dai et al., 2007;Ruparel et al., 2008;
Wang et al., 2008a). The mechanism for this is not completely
understood, but involves calcium (in inside-out patches without
calcium this desensitization is not observed) (Macpherson
et al., 2007; Wang et al., 2008b). We assayed nocifensive
behavior to consecutive application of MO to the same region
of the hindpaw and asked whether a second response could be
elicited. Although the two injections were directed to the same
location in the hindpaw, we cannot say with certainty that the
same neuronal endings were exposed. Mice responded to the
first injection of MO with only minor nocifensive behavior (Fig-
ure 1C). Nocifensive responses were strongly enhanced upon
the second injection of MO. This effect was specific to injection
of MO, as injection of vehicle resulted in significantly reduced
nocifensive behavior (Figure 1C). Interestingly, the observed
sensitization of nocifensive responses to a secondMO challenge
was significantly stronger than responses to a single injection of
twice the amount ofMO (Figure 1C). To control for potential olfac-
tory-related effects of the pungent odor of MO in our paradigm,
we assayed nocifensive behavior to consecutive injections of
MO or vehicle in the presence of a pad containing the amount
of MO that we normally injected (10 ml of 10 mM MO). Adding
this MO-containing pad into the test cage of both experimental
and control groups during the evaluation of the second injectionNeuron 64, 498–509, November 25, 2009 ª2009 Elsevier Inc. 499
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Regulation of TRPA1 Levels at the Plasma MembraneFigure 2. Specificity of TRPA1 Antibodies
(A) Cryosections of wild-type (WT) adult TG neurons (left) show staining for TRPA1 whereas TG neurons of Trpa1-deficient animals (A1 KO, right) are devoid of
staining. Scale bar = 50 mm.
(B) TRPA1-positive TG express the nociceptive marker CGRP (upper panel). TG from Trpa1-deficient animals (A1 KO) exhibit CGRP staining (lower panel), but are
devoid of TRPA1 staining. Scale bar = 30 mm.
(C) Heterologous expression of TRPA1-MYC in HEK293T cells. Cells were live-labeled with TRPA1 antibodies (AbE1, green), fixed, permeabilized, and stained for
WGA (red) and MYC (blue). Only cells exhibiting MYC labeling are detected by TRPA1 antibodies. TRPA1 labeling is restricted to the cell surface as indicated by
comparison with the staining pattern of WGA. Scale bar = 20 mm.did not influence the experimental outcome (data not shown).
From this set of data we conclude that the odor of MO does
not influence the nocifensive behavior of either group. Taken
together, these observations suggest that TRPA1 channels can
be sensitized in vivo by either inflammatory signals or electro-
philic activators of TRPA1. To gain insight into mechanisms of
dynamic regulation of TRPA1 function, we focused on creating
tools to study TRPA1 localization.
Live-Labeling of the Surface Population of TRPA1
Channels in HEK293T Cells
Fluorescent tagging of TRPA1 (GFP fusions to N and C termini of
TRPA1, as well as a random insertion approach) did not yield
functional channels. In an effort to visualize TRPA1 channels at
the surface of live cells, we generated peptide antibodies
directed against two epitopes (AbE1, AbE3) in extracellular loops
1 and 3 of murine TRPA1 (mTRPA1). Antisera specificity was
determined by indirect immunohistochemistry on cryosections
of TG from wild-type and Trpa1-deficient mice (Figure 2A).500 Neuron 64, 498–509, November 25, 2009 ª2009 Elsevier Inc.TRPA1 staining was observed in roughly 8% of wild-type
neurons (n = 3516 from four mice; see also results below), while
no detectable labeling was present in neurons from Trpa1-
deficient mice prepared in parallel. Both antibodies gave similar
results. We expect that neurons with relatively high TRPA1
expression are labeled because previous studies using in situ
hybridization reported 3.6% to 36.5% of TG neurons being posi-
tive for Trpa1 mRNA (Diogenes et al., 2007; Nagata et al., 2005;
Story et al., 2003). Colabeling with CGRP, a marker for nocicep-
tive neurons, revealed that TRPA1-positive neurons are also
positive for CGRP (Figure 2B) as described in earlier reports
(Bautista et al., 2005; Story et al., 2003).
We next attempted to detect the surface population of TRPA1
channels in Human Embryonic Kidney (HEK) 293T cells tran-
siently transfected with a murine Trpa1-MYC/His construct
(Macpherson et al., 2007). HEK293T cells were incubated with
AbE1 at 37C for 10min, washed to remove unbound antibodies,
and treated with F(ab’)2 fragments conjugated to Alexa Fluor 488
at room temperature for another 10 min. Figure 2C shows
Neuron
Regulation of TRPA1 Levels at the Plasma MembraneFigure 3. The Intensity of TRPA1 Membrane Staining and Functionality Is Modulated by PKA and PLC Signaling
(A) Representative images of live-labeling of surface TRPA1 channels, and brightfield images of the respective field of view after application of vehicle (EtOH) and
FSK and m-3m3FBS (30 mM and 25 mM, respectively) to TRPA1-expressing HEK293T cells. Scale bar = 20 mm.
(B) Quantitation of the mean fluorescence intensity of TRPA1 labeling in vehicle (n = 51) and FSK and m-3m3FBS-treated cells (n = 64).
(C) Quantitation of the mean fluorescence intensity of TRPA1 labeling in vehicle (n = 124) and FSK-treated cells (100 mM; n = 123).
(D) Quantitation of the mean fluorescence intensity of TRPA1 labeling in vehicle (n = 83) compared with m-3m3FBS-treated cells (60 mM; n = 82).
(E) FLIPR-based calcium imaging of TRPA1-expressing HEK293T cells. Cells were incubated with FSK (100 mM) or vehicle before the addition of MO (0.3 mM).
Quantitation of the mean amplitude of TRPA1-mediated calcium influx upon pretreatment with vehicle (n = 16 wells, 8000 cells/well) and FSK (n = 16 wells,
8000 cells/well) is shown.
(F) Ratiometric calcium imaging of cultured DRG neurons. Neurons were incubated with FSK (100 mM) and m-3m3FBS (50 mM) or vehicle before the addition of
MO (5 mM). Quantitation of the mean percentage of responding DRG neurons upon pretreatment with vehicle (6.1% ± 2.8%, n = 720 neurons) and FSK and
m-3m3FBS (27.42% ± 5.8%, n = 480 neurons) is shown. p = 0.019.
*p < 0.05, ***p < 0.001, Mann-Whitney test. Error bars = SEM.representative z-stacks of HEK293T cells live-labeled for surface
TRPA1 (green). The surface staining exhibited a clear punctate
pattern. This was distinct from the signal obtained when visual-
izing the total population of TRPA1-MYC with a MYC antibody
after fixation and permeabilization (blue). A wheat germ agglu-
tinin (WGA) Alexa Fluor 555 conjugate was used to delineate
membranes (red). Importantly, surface labeling was specific for
TRPA1, as only TRPA1-MYC-expressing cells were stained.
Loss of TRPA1-membrane signal upon acid stripping (Beattie
et al., 2000) indicates that the observed staining indeed reflected
surface labeling (Figure S1 available online).
Regulation of Membrane Levels and Functionality
of TRPA1 in Response to PKA/PLC Activators
Having established live-labeling of surface TRPA1, we tested
whether activation of PKA and PLC pathways in HEK293T cells
expressing TRPA1 might serve as a molecular correlate of the
sensitization of TRPA1 observed in vivo. Remarkably, applica-
tion of FSK and m-3m3FBS significantly increased the levels of
TRPA1 at the membrane (Figures 3A and 3B). Figure 3A shows
representative images obtained after FSK and m-3m3FBS
application comparedwith vehicle. For quantitation of this effect,
the mean fluorescence intensity of TRPA1 surface label was
measured and FSK and m-3m3FBS-treated cells were com-
pared with vehicle-treated cells (Figure 3B). Application ofeither substance alone at these concentrations did not alter
TRPA1 surface label. However, similar to our behavioral results
(Figure 1B), application of higher concentrations of FSK or
m-3m3FBS resulted in an increase of TRPA1 surface labeling
(Figures 3C and 3D), albeit not to the same extent as the combi-
nation of both compounds at lower concentrations (Figure 3A). A
similar, potentially additive effect of FSK and m-3m3FBS on
TRPA1-mediated currents has been reported by Wang and
colleagues (Wang et al., 2008a). Our results indicate that
TRPA1 channels might be actively translocated to the
membrane. Next, we tested whether the newly recruited chan-
nels might be functional. We performed fluorometric imaging
plate reader (FLIPR)-based calcium imaging of transfected
HEK293T cells. Of note, m-3m3FBS induced calcium influx in
TRPA1-expressing HEK293T cells (Bandell et al., 2004), likely
due to activation of PLC pathways because this activation was
strongly attenuated by the PLC inhibitor edelfosine (ET-18-
OCH3, or ET) (data not shown). For this reason, we focused on
FSK in FLIPR-based calcium imaging. Incubation of TRPA1-
expressing HEK293T cells with FSK 7 min before addition
of low concentrations of MO potentiated TRPA1-mediated
responses (Figure 3E). We also tested whether endogenous
TRPA1 channels in cultured sensory neurons are sensitized by
PKA and PLC signaling pathways. In contrast to our studies on
overexpressed TRPA1 in HEK293T cells, cultured sensoryNeuron 64, 498–509, November 25, 2009 ª2009 Elsevier Inc. 501
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Regulation of TRPA1 Levels at the Plasma MembraneFigure 4. MO-Induced Activation of TRPA1 Increases TRPA1 Surface Labeling
(A) Representative images of live-labeling of surface TRPA1 channels and brightfield images of the respective field of view after application of vehicle (DMSO) and
MO (100 mM, 1 min) to TRPA1-expressing HEK293T cells. Scale bar = 20 mm.
(B) Quantitation of the mean fluorescence intensity of TRPA1 labeling in vehicle-treated cells (n = 72), MO-treated cells (n = 75), and MO-treated cells preincu-
bated with FSK and m-3m3FBS (30 mM and 25 mM, respectively; n = 34).
(C) MO-dependent increase of TRPA1 surface levels can be attenuated by blockade of PKA and PLC signaling by application of H89 (20 mM) and ET (10 mM).
Quantitation of the mean fluorescence intensity of TRPA1 surface labeling in vehicle-treated (n = 51) versus MO-treated (n = 42) cells compared with the
same treatments in the presence of H89 and ET (vehicle n = 34; MO n = 60) is shown.
(D) MO-dependent increase of TRPA1 surface labeling is abolished in the absence of extracellular calcium (vehicle n = 35; MO n = 43).
(E) Coexpression of TRPA1 and TRPV1. Quantitation of the mean fluorescence intensity of TRPA1 membrane labeling upon application of CAPS (1 min, 1 mM,
n = 46) and vehicle (DMSO, n = 43) is shown. ***p < 0.001, Mann-Whitney test.
(F) Quantitation of the mean fluorescence intensity of TRPA1 labeling in cells treated with vehicle (n = 38), MO (n = 44), and ATP (100 mM, 1 min; n = 48).
**p < 0.01, ***p < 0.001, one-way ANOVA followed by Bonferroni’s multiple comparison test. Error bars = SEM.neurons did not exhibit m-3m3FBS-induced calcium influx
(Figure S2) and we were able to test for sensitization of MO
responses using a combination of FSK and m-3m3FBS. In
accordance with our behavioral data and TRPA1 live-labeling
in HEK293T cells, we observed an increase in the number of
responding neurons to MO after pretreatment with FSK and
m-3m3FBS (Figures 3F and S2). In summary, our data suggest
that TRPA1 channels actively translocate to the membrane and
that these channels might be functional.
Activation of TRPA1 by MO Increases TRPA1 Surface
Labeling
We next sought to explore whether TRPA1 activation by its
specific agonist MO could increase TRPA1 at the membrane.
Indeed, incubation of TRPA1-espressing HEK293T cells with
MO resulted in a pronounced increase in surface labeling
compared with incubation with vehicle (Figures 4A and 4B).
We then addressed the mechanism or mechanisms by which
TRPA1 surface levels were increased. First, we examined the
potential involvement of PKA and PLC signaling and pretreated
transfected HEK293T cells with FSK and m-3m3FBS before502 Neuron 64, 498–509, November 25, 2009 ª2009 Elsevier Inc.exposure to MO. We did not detect any further enhancement
of TRPA1 surface levels (Figure 4B). On the other hand, coappli-
cation of a PKA inhibitor (N-[2-(p-Bromocinnamylamino)ethyl]-
5-isoquinolinesulfonamide dihydrochloride, or H89) and the PLC
inhibitor ET attenuated the MO-induced increase in TRPA1
surface staining (Figure 4C). Basal levels of TRPA1 were unaf-
fected by H89 and ET (Figure 4C), and neither H89 nor ET
blocked MO-mediated TRPA1 activity. These results suggest
that TRPA1 activation enhances TRPA1 expression at the
membrane, and that this is at least partly dependent on activa-
tion of PKA/PLC. One of the consequences of MO-induced
TRPA1 activation is a rise of intracellular calcium since TRPA1
is a nonselective cation channel. We therefore tested the influ-
ence of calcium on TRPA1 surface levels. First, MO was applied
in calcium-free solution, which allows channel activity, but not
calcium influx. Under these calcium-free conditions, MO did
not affect TRPA1 surface labeling (Figure 4D). This demonstrates
that calcium influx through TRPA1 is required for MO-induced
increased surface levels. Of note, this result argues against the
possibilities that (1) the observed effects on TRPA1 surface
levels might simply be due to the reactive nature of MO
Neuron
Regulation of TRPA1 Levels at the Plasma MembraneFigure 5. Activation of TRPA1 byMO Acutely Affects the Abundance
of Observed Endogenous TRPA1 Channels
(A) Explants of TGwere incubated with vehicle (DMSO) or MO (100 mM, 15min)
and immediately fixed, and cryosections were stained with TRPA1 antibodies.
Scale bar = 50 mm.
(B) Quantitation of the average percentage of TRPA1-positive neurons upon
vehicle (7.7% ± 1.1%; n = 3516 neurons) and MO (12.2% ± 0.5%; n = 4548
neurons) application (n = 4 animals). p = 0.028, Mann-Whitney test.
(C) Representative images of live-labeling of endogenous TRPA1 in
cultured DRG neurons after application of vehicle and MO (100 mM, 1 min).
Scale bar = 20 mm.
(D) Quantitation of the mean fluorescence intensity of TRPA1 surface labeling
in neurons incubated with vehicle (n = 23) and MO (n = 25). p = 0.028, Mann-
Whitney test.
(E and F) Ratiometric calcium imaging in cultured DRG from wild-type mice
(vehicle: n = 206 neurons/animal; Tetx: n = 280 neurons/animal; n = 5 animals).
(E) Paired analysis of the fraction of DRG neurons responding to the first pulse
of MO in presence of vehicle (29.2% ± 3.3%) and Tetx (33.1% ± 3.2%). (F)
Paired analysis of the fraction of DRG neurons responding to the second pulse(Macpherson et al., 2007) and independent of its ability to acti-
vate TRPA1, and (2) binding of TRPA1 antibodies might be
enhanced upon TRPA1 activation. As TRPA1 is highly coex-
pressed with TRPV1 in sensory neurons (Story et al., 2003), we
further askedwhether activation of TRPV1 and its accompanying
calcium influx increased TRPA1 membrane expression. Rat
TRPV1 was coexpressed with TRPA1 in HEK293T cells and
activated by capsaicin (CAPS). Interestingly, TRPA1 surface
staining increased upon CAPS treatment (Figures 4E and S3A),
while TRPV1 levels were unchanged (Figures S3A and S3B).
Our data on TRPV1 are in accordance with a previous report
showing that TRPV1 surface expression is not affected by
CAPS (Bao et al., 2003). We then investigated whether a general
rise of intracellular calcium could cause an increase in surface
levels of TRPA1. Addition of ATP to TRPA1-expressing cells to
cause calcium release from intracellular stores via endogenous
P2Y receptor activation did not alter the abundance of TRPA1
channels at the membrane compared with vehicle controls
(Figure 4F).
We propose that localized calcium influx upon TRPA1 and
TRPV1 activation increases surface expression of TRPA1
whereas a more general elevation of intracellular calcium does
not. These data are consistent with the notion that localized
calcium changes in microdomains form the basis for many
cellular processes (Oheim et al., 2006).
Acute Upregulation of Endogenous TRPA1 in Sensory
Neurons
Next, we investigated whether endogenous TRPA1 in sensory
neurons exhibited a similar augmentation of surface levels
upon MO-induced channel activity. Several reports showed
enhanced expression of TRPA1 after application of various pain-
ful stimuli (Ji et al., 2008; Obata et al., 2005). These studies inves-
tigated long-term effects on Trpa1 mRNA levels. Nonetheless,
our data using heterologously expressed TRPA1 suggested an
acute regulation of TRPA1 protein. To test this in situ, we incu-
bated explants of TG with MO, obtained cryosections, and
stained for TRPA1. MO-treated explants exhibited significantly
greater numbers of TRPA1-positive neurons when compared
with vehicle-treated controls (Figures 5A and 5B). In contrast,
staining for the nociceptive marker peripherin was unchanged
(data not shown). This result is in accordance with our experi-
ments in HEK293T cells showing that activation of TRPA1
causes its rapid upregulation.
Since immunohistochemistry on fixed and permeabilized
tissue is not suited for differentiating among effects on transla-
tion, posttranslational modifications, or trafficking of TRPA1,
we performed live-labeling of endogenous TRPA1 channels in
cultured DRG neurons. We obtained a punctate pattern of
surface staining similar to that observed with transfected
HEK293T cells; however, the efficiency of TRPA1 live-labeling
was very low in cultured DRG neurons. Only 1% of cultured
neurons appeared to be TRPA1 positive, in contrast to 29%
of MO in presence of vehicle (20.2% ± 3.0%) and Tetx (15.8% ± 3.2%).
p = 0.0005, paired Student’s t test.
Error bars = SEM.Neuron 64, 498–509, November 25, 2009 ª2009 Elsevier Inc. 503
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Regulation of TRPA1 Levels at the Plasma Membraneof neurons responding to MO in ratiometric calcium imaging
experiments (Bautista et al., 2006) (see results below). This
discrepancy is likely due to limited sensitivity of our antibodies
to the low levels of endogenous TRPA1. Nevertheless, the
observed surface staining was specific for TRPA1, because
neurons derived from Trpa1-deficient animals were devoid of
signal (data not shown). In accordance with the data presented
above, addition of MO to these neurons resulted in significant
recruitment of TRPA1 channels to the plasma membrane
(Figures 5C and 5D).
Evidence for Vesicle-Mediated Membrane
Translocation of TRPA1
Collectively, we show here that heterologously expressed and
native TRPA1 levels at the cell surface can be increased in
response to various signals, including TRPA1 activity. Further-
more, we demonstrate that calcium is required for the MO-
induced increase of TRPA1 levels in HEK293T cells. An increase
in surface receptors could be accomplished by two different
processes: attenuation of constitutive endocytosis/retrieval of
TRPA1 channels from the membrane, or induced delivery and
insertion of TRPA1 channels into the membrane. These two
mechanisms are not mutually exclusive, and a combination
of both is possible. To elucidate whether increased TRPA1
membrane levels are at least partly due to exocytotic insertion
of TRPA1, sensory neurons were incubated with tetanus toxin
(Tetx), a potent inhibitor of vesicle fusion via proteolysis of the
requisite synaptic vesicle SNARE protein VAMP2 (Link et al.,
1992). Tetx has been shown to block calcium-evoked dendritic
exocytosis (Maletic-Savatic and Malinow, 1998) and attenuate
AMPA receptor insertion into the postsynaptic membrane (Lu
et al., 2001; Tatsukawa et al., 2006). Control neurons and Tetx-
treated neurons were subjected to ratiometric calcium imaging
using a two-pulse protocol of MO (Figures S4A, S4B, 5E, and
5F). The initial pulse of MO (30 mM, 2 min) was applied to deter-
mine MO-responsive (i.e., TRPA1-expressing) neurons and
trigger surface translocation of TRPA1 (Figure 5E). Nine minutes
later a second application ofMO (150 mM, twominutes) was used
to assess the levels of functional TRPA1 channels and thereby
represented a read-out of TRPA1 sensitization (the higher
concentration of MO in the second pulse is to compensate for
the expected desensitization of TRPA1 responses previously
described [Hinman et al., 2006; Macpherson et al., 2007]). The
prediction is that Tetx-treatedcoverslipswouldexhibit a relatively
reduced number of neurons responding to the second MO pulse
if MO-induced increase in TRPA1 membrane levels is due to
active exocytosis. Indeed, Tetx treatment attenuated the second
response to MO (Figure 5F). Importantly, Tetx had no significant
effect on either the number of responders to the first pulse of MO
(Figure 5E) or the amplitudes (Figures S4A and S4B), indicating
that cultures were healthy and basal TRPA1 expression was not
grossly altered by Tetx. These data suggest that activation of
TRPA1 byMO induces active delivery and insertion of new chan-
nels into the membrane of sensory neurons, and, importantly,
that a proportion of these channels are functional.
Vesicle-mediated fusion can also be investigated using
voltage-clamp techniques monitoring membrane capacitance
(Cm) (Neher and Marty, 1982). We therefore examined whether504 Neuron 64, 498–509, November 25, 2009 ª2009 Elsevier Inc.MO could increase the membrane surface area of TRPA1-
expressing DRG neurons. Previous reports on cultured DRG
neurons have shown exocytosis to occur in response to depolar-
ization (Huang and Neher, 1996). We reasoned that focal appli-
cation of MO via the patch pipette might increase Cm in a
TRPA1-dependent manner. We tested small- to medium-diam-
eter neurons of wild-type and Trpa1-deficient (KO) cultures and
monitored Cm of cell-attached patches of membrane for at least
5 min after sealing (Figures S5A and S5B). Forty percent of the
patches from wild-type DRG exhibited specific changes in Cm
with an average latency of 230 ± 50 s (Figure 6A, red bars;
Figure 6B, wild-type). The rise in Cm required TRPA1, since
comparable changes of Cmwere not observed in Trpa1-deficient
DRG neurons (Figures 6A and S5B). Only 2 of 45 patches from
Trpa1-deficient neurons revealed increases in surface area
(Figure 6A, gray bars, inset), and the increases were significantly
lower than those fromwild-type patches (Figure 6B). The depen-
dence on TRPA1 is not an artifact of the cells chosen for study
(assessed by cell diameter) electrode resistance, patch capaci-
tance, or the ratio of series conductance to membrane conduc-
tance (Gs/Gm), because these parameters were not different
between genotypes. Even though a few membrane patches
revealed transient TRPA1-like conductance changes shortly
after seal formation (n = 8 of 50) that were not observed in
Trpa1-deficient neurons (n = 45), our recordings did not allow
us to determine whether fusing vesicles contain TRPA1 channels
(potentially due to desensitization of TRPA1 under these
recording conditions and limited resolution of gating events). In
summary, the capacitance recordings are in agreement with
our previous data showing higher abundance of TRPA1 at the
surface and involvement of vesicle-mediated fusion.
DISCUSSION
Preservation of sensitivity and sensitization of nociceptive
neurons play an important role in acute and chronic pain trans-
duction (Zhang and Bao, 2006). Numerous mechanisms includ-
ing the release of inflammatory mediators and subsequent
modulation of ion channels have been shown to be involved in
these processes (Hucho and Levine, 2007;McMahon and Jones,
2004;Scholz andWoolf, 2002).Our study investigated thecellular
regulation of TRPA1, an ion channel with a unique mechanism of
activation involved in transducing noxious signals.We generated
specific antibodies against extracellular regions of murine
TRPA1,whichenabledselective visualizationof surface-exposed
TRPA1 channels in heterologous expression systems and
primary sensory neurons. Our live-labeling experiments reveal
increases in surface TRPA1 in response to seemingly different
stimuli: pharmacological activators of PKA and PLC, the
TRPA1-specific agonist MO, and the TRPV1-specific agonist
capsaicin. Importantly, our in vitro observations on the regulation
of TRPA1membrane levels correlatewell with the effects of these
stimuli on TRPA1-mediated responses in vitro and nocifensive
behavior in animals. These data suggest that translocation of
TRPA1 to the membrane is likely to be physiologically relevant
in vivo, contributing to TRPA1 functionality and sensitization.
Many receptors and ion channels cycle between the plasma
membrane and intracellular compartments, and the balance
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Regulation of TRPA1 Levels at the Plasma MembraneFigure 6. MOCauses an Increase in Cell-Attached PatchMembraneCapacitance inWild-Type, but Not Trpa1-Deficient (KO), Small-Diameter
Sensory Neurons
(A) Histogram of the percent increase of surface area observed in wild-type (red) and Trpa1 KO (gray) neurons. Dashed line indicates two times the
standard deviation of the average increase in surface area observed for patches from Trpa1 KO cells. Responding patches are those with changes in surface
area >2.5%. (Inset) The percent responders for wild-type and Trpa1 KO neurons among the total number of cells tested (n). p < 3e6; chi-square test.
(B) Box plots of the percent increase in surface area for responders toMO (10.9%± 2.1%, n = 20) and nonresponders (n = 30) from cultures derived fromwild-type
andTrpa1KOmice (total n = 45). The twooutlier Trpa1KO responding cells arewell below the lower quartile of thewild-type responders. p< 0.002, Student’s t test.
Error bars = SEM.between membrane insertion and retrieval determines their
surface abundance and activity (Ambudkar, 2007; Malenka,
2003; Shepherd and Huganir, 2007). Three observations
reported here support the existence of such a regulation for
TRPA1 channels: (1) PKA/PLC signaling, CAPS, and activation
of TRPA1 by MO enhance the availability of TRPA1 at the
membrane in HEK293T cells and in sensory neurons. (2) MO
application to DRG neurons induced an increase in Cm. This is
indicative of incorporation of new membrane into the neuronal
surface, which can be caused by membrane-fusion-dependent
events (Huang and Neher, 1996). (3) Application of Tetx selec-
tively attenuated the response of cultured DRG to a second
MOpulse. Taken together, these data suggest that the increased
TRPA1 membrane availability observed upon MO application is
at least partially dependent on SNARE-mediated vesicle fusion.
An interesting feature of this process is the lack of action of Tetx
on the initial MO response, which presumably reflects basal
receptor levels. This may be indicative of Tetx-independent/
insensitive exocytosis at steady state, possibly involving
different SNARE proteins (Galli et al., 1998; Holt et al., 2008;
Meng et al., 2007). Alternatively, incomplete proteolysis of
VAMP2 by Tetx might be sufficient to maintain constitutive
TRPA1 insertion. On the other hand, MO-induced membrane
translocation might require more rapid fusion events than at
steady state and VAMP2 levels might become limiting. Similar
findings are reported for activity-induced insertion and recycling
of AMPA receptors (Lu et al., 2001; Tatsukawa et al., 2006).
Collectively, our data suggest a translocation of functionalTRPA1 channels to the membrane; however, we cannot exclude
an attenuation of endocytotic events contributing to enhance
surface labeling. One question that remains unsolved is the
identity of intracellular vesicles containing TRPA1 channels.
New tools including more sensitive antibodies to TRPA1 will be
required for future studies.
Interestingly, the MO-mediated increase in TRPA1 membrane
expression can be attenuated by pharmacological blockade of
PKA and PLC signaling. PKA and PLC activation, therefore,
appear to be required downstream of TRPA1 activation and
might provide a link between these two pathways. This notion
is supported by previous studies showing TRPA1 activity upon
PLC-dependent signaling in heterologous systems (Bandell
et al., 2004). PLC activity affects cellular signaling by breakdown
of phosphatidylinositides (PIP2) into diacylglycerol (DAG) and
inositol triphospate (IP3). While OAG, a membrane-permeable
DAG analog, has been reported to activate TRPA1 (Bandell
et al., 2004), the role of PIP2 on TRPA1 is not settled. PIP2 might
promote TRPA1 activity (Akopian et al., 2007), but PIP2-depen-
dent inhibition of TRPA1 is also described (Dai et al., 2007).
Further experiments are needed to determine the underlying
mechanism and pathways of PLC-dependent TRPA1 sensitiza-
tion. The possibility that PKA signaling and MO-induced TRPA1
activation might be linked is raised by a study on visceral pain
induced by intracolonic injection of MO in rats (Wu et al., 2007).
In this report, PKA activation appears to be a critical player in
this pain model, because blockade of the PKA cascade partially
reverses visceral-pain-induced effects. However, unequivocalNeuron 64, 498–509, November 25, 2009 ª2009 Elsevier Inc. 505
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TRPA1 activation has not yet been demonstrated.
PKA and PLC are known instigators of inflammation and noci-
ceptor sensitization, and their effects on cell signaling and
neuronal inflammation can be diverse (Hucho and Levine,
2007). Many ion channels and receptors involved in pain
signaling are phosphorylated by PKA, among them TRPV1 and
the sodium channel Nav1.8 (Bhave et al., 2002; Fitzgerald
et al., 1999; Mohapatra and Nau, 2003). The phosphorylation
status of receptors has been proposed to regulate channel
activity and/or trafficking to the membrane (Esteban et al.,
2003; Fabbretti et al., 2006; Zhang et al., 2005). In addition,
PKA and PLC signaling cascades have been implicated in the
regulation of vesicle-mediated fusion events (Holz and Axelrod,
2002; James et al., 2008; Seino and Shibasaki, 2005). In the
context of TRPA1, PKA and PLC might be part of a multifactorial
complex that controls surface expression of TRPA1. Future
studies will investigate whether posttranslational modifications
of TRPA1 and/or changes in the protein scaffold contribute
to TRPA1 membrane expression. Furthermore, it will be of
particular interest if similar mechanisms regulate TRPA1 mem-
brane levels at the sensory nerve endings in the periphery, in
agreement with what we observe in neuronal somata. The
behavioral experiments showing sensitized TRPA1-mediated
pain responses presented here suggest that this may be the
case. To this end, sensitive tools for visualizing TRPA1 channels
at sensory nerve endings in the plantar surface of mice hindpaws
would have to be established.
Despite intensive study of TRPA1 and identification of a
plethora of agonists, its molecular regulation and trafficking
remain to be elucidated. Moreover, knowledge about these
processes is key to understanding the role of this important
transduction channel in acute and inflammatory pain. The data
presented here suggest that activation of sensory neurons via
distinct but potentially linked mechanisms could enhance
TRPA1 membrane insertion, resulting in higher amounts of func-
tional TRPA1 channels at the surface. We propose that this
process at least partly contributes to the regulation of nociceptor
sensitivity to TRPA1 agonists.
EXPERIMENTAL PROCEDURES
Reagents
MO, dimethyl sulfoxide (DMSO), m-3m3FBS, FSK, Tetx, ET, and H89 were
purchased from Sigma Aldrich (St. Louis, MO). Stock solutions were made
as follows: MO and ET were dissolved in DMSO, Tetx in PBS, H89 in H2O,
and FSK and m-3m3FBS in EtOH.
Generation of TRPA1 Sera
Synthetic peptides were designed against extracellular domains of murine
TRPA1 selected by using Kyte-Doolittle Hydrophilicity plots (Lasergene,
DNAStar). Custom polyclonal antibodies to synthetic peptides TSSTHEERIDT
(AbE1, in extracellular loop 1) and GDINYRDAFLEPLFRN (AbE3, in extracel-
lular loop 3) were prepared in rabbit by standard methods and affinity purified
(Imgenex Corp., San Diego, CA). Sera were dialyzed in PBS.
Behavior
All behavior analyses were conducted on 6- to 8-week-old male C57Bl6 mice.
Mice were acclimated for 20 min in a transparent Plexiglas box at room
temperature. Ten microliters of experimental agent (for more details see506 Neuron 64, 498–509, November 25, 2009 ª2009 Elsevier Inc.respective experiment in Results) or of vehicle solution were injected subcuta-
neously into the plantar surface of the left hindpaw. Pain responses were
measured by counting the time spent licking, flicking, or lifting the injected
paw for 5 min. Seven to ten minutes later, mice were injected into the same
position with 10 ml of the respective agents in solution (for more details see
respective experiment in Results). Acute pain was determined by measuring
the time spent licking, flicking, or lifting the injected paw for 5 min after the
second injection. All groups to be compared were assessed in parallel. All
experiments were conducted with the approval of The Scripps Research Insti-
tute Animal Research Committee.
TRPA1 Live-Labeling and Immunocytochemistry
HEK 293T cells were maintained at 37C, 5% CO2 in DMEM containing 10%
FBS and antibiotic/antimycotic (Invitrogen). After transient transfection with
1.2 mg of a murine Trpa1-MYC/His construct (Macpherson et al., 2007), cells
were plated on poly-D-lysine-coated glass bottom dishes (MatTek), which
were additionally coated with laminin (2 mg/ml). Cells were used 18–24 hr after
transfection. All groups to be compared were processed in parallel using the
same culture preparation. Pharmacological agents were applied in culture
medium at the concentrations and times indicated. For experiments under
calcium-free conditions, pharmacological agents and TRPA1 antibodies
were applied in calcium-free 1x Hank’s balanced salt solution (HBSS) (Invitro-
gen) and 10mMHEPES (Invitrogen), supplemented with 5mMEGTA. H89, ET,
FSK, and m-3m3FBS were preincubated for 4 min before addition of MO or
vehicle and were present throughout the incubation with the TRPA1 antibody.
Surface TRPA1was labeled by incubating live HEK293T cells with TRPA1 anti-
bodies (AbE1, 1:50) in prewarmed culture medium for 10 min at 37C. Cells
were washed five times with prewarmedmedia and incubated with Alexa Fluor
488 F(ab’)2 fragment of goat-anti-rabbit (1:200, Invitrogen) for 10 min at room
temperature. Cells were then washed three times in medium and once in PBS,
then fixed with 2% paraformaldehyde (PFA) in PBS for 20 min at room temper-
ature. Specificity of antibody labeling was assessed by applying the same
protocol to HEK293T cells expressing rat TRPV1 and by omission of the
primary antibody. Neither control exhibited any label. Exclusive membrane
staining with this protocol was tested using a brief acid wash (1 min, 0.5 M
NaCl, 0.2 N acetic acid [Beattie et al., 2000]), which removed any live-labeling.
In some cases cells were subjected to immunocytochemistry after PFA fixa-
tion. Cells were permeabilized in PBS containing 0.4% Triton X-100, blocked
with normal goat serum or normal donkey serum (10% serum in PBS), and
incubated with primary antibodies. The following primary antibodies were
used: TRPV1 (1:50, goat, Santa Cruz Biotechnology); c-MYC (1:100, 9E11,
mouse, Santa Cruz Biotechnology); and WGA Alexa Fluor 555 conjugate
(1:200, Invitrogen). After three washes in PBS secondary antibodies were
added.We used either Alexa Fluor 633 goat-anti-mouse IgG (1:200, Invitrogen)
or Alexa Fluor 568 donkey-anti-goat IgG (1:200, Invitrogen).
Endogenous TRPA1 channels in cultured DRG neurons were similarly
labeled, but TRPA1 antibodies were diluted at 1:25. Cultured DRG from
Trpa1-deficient animals (Kwan et al., 2006) stained the same way were devoid
of staining and served as specificity control for TRPA1 antibodies. Preparation
of DRG cultures is outlined in Supplemental Experimental Procedures.
Image Acquisition and Data Analysis
TRPA1 live-labeling experiments in HEK293T cells were imaged at a Zeiss
Axiovert 200 microscope (Carl Zeiss MicroImaging) using a 63x 1.4 NA
PlanAPO oil-immersion objective, a Hamamatsu Orca-ER-II digital camera,
and MetaMorph software (Molecular Devices). Images for all experimental
groups were taken using identical acquisition parameters. All groups to be
compared were processed simultaneously using the same culture prepara-
tion. For each experimental group at least 10 cells were randomly analyzed
from each preparation and experiments were done using at least three inde-
pendent preparations. Raw images were analyzed using ImageJ software
(ImageJ, NIH). The mean surface fluorescence intensity (AU) of each cell
was determined by drawing a region of interest (ROI) carefully encircling the
surface of each cell with the selection brush tool (pixel width 5). Values for
background fluorescence for each individual cell were obtained by drawing
a circular ROI exactly outside the cell surface. Mean background fluorescence
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These values were averaged among experiments.
TRPV1 surface levels were assessed in parallel with TRPA1 surface levels
when both channels were coexpressed in HEK293T cells. TRPA1 live-label
was used as a reference to delineate the membrane of each cell and was
determined as described above. The respective ROI of each cell was then
transferred to TRPV1 images and the mean surface fluorescence intensity
for TRPV1 was determined as described above for TRPA1.
Immunocytochemistry on HEK293T cells and TRPA1 live-labeling experi-
ments on cultured DRG neurons were imaged at an Olympus (Tokyo, Japan)
Fluoview 500 confocal microscope by sequential illumination using the 488
nm line of an argon laser, the HeNe green 543 nm laser, and the HeNe red
633 nm laser. Merge-stacked images were created using a 60x 1.4 NA Pla-
nAPO oil-immersion objective. All groups to be compared were processed
in parallel using the same DRG culture preparation (four independent DRG
preparations were used). The analysis of the mean fluorescence surface inten-
sity was carried out on a single image plane from the middle of each stack as
described above for HEK293T cells.
Capacitance Recordings
DRG from wild-type or Trpa1-deficient mice (wild-type littermates gave similar
results as colony C57Bl6) were recorded 18–48 hr after plating on poly-
D-lysine/laminin coated coverslips. Cells were continuously perfused at
27C –28C with extracellular solution (2 mM Ca2+ ES) containing (in mM):
136 NaCl, 5 KCl, 2 MgCl2, 2 CaCl2, 10 dextrose, and 10 HEPES (pH 7.4).
Temperature was controlled with an in-line heater, CL-100 (Warner Instru-
ments). Patch pipettes were fabricated from B150-86 glass (Sutter Instrument
Comp., Novaro, CA) and coated with Surgident Dental Periphery Wax
(Heraeus, South Bend, IN). Pipette resistanceswere 0.7–2.0MOhmwhen filled
with 2 mM Ca2+ ES (tip) and backfilled with 2 mM Ca2+ ES containing 100 mM
MO. Seals were made quickly (within 1 min of backfilling) and Cm measure-
ments were initiated immediately. Recordings were made using an EPC-9
patch-clamp amplifier (HEKA Elektronic, InstruTECH Corp.,) with a built-in
two-phase analog lock-in amplifier (Gillis, 2000; Lollike and Lindau, 1999).
Admittance-based Cm measurements were performed using the ‘‘sine+dc’’
method using a 15 mV sine wave command voltage (Gillis, 2000; Lindau and
Neher, 1988). Frequencies ranged from 1500 (67 ms, 15 kHz sampling rate)
to 6000 Hz (14 ms, 71 kHz) to improve recordings (Debus and Lindau, 2000),
and currents were filtered at 10 kHz and 30 kHz, respectively. Pipette holding
potential was 0mV. The continuous buffer was set to 14.2M samples to enable
prolonged recordings. Cm, Gm, and Gs components of the current recording
were derived using a reversal potential of 60 mV. To avoid changes in Cm
due to inadequate separation of Cm from Gm and Gs, data were included if
calculated changes in Cm were not mirrored in Gm or Gs. While an early Cm
change was observed in patches from both genotypes and may be due to
effects arising from the sealing process, fluctuations that occurred at >50 s
after sealing were very rarely observed in Trpa1-deficient DRG neurons.
Average basal Cm for wild-type was 320 ± 20 fF and 340 ± 18 fF for Trpa1-defi-
cient neurons. Exocytosis induced by a +120 mV step for 1 s from separate
cells of both genotypes served as a positive control, for the ability to increase
Cm induced by a known stimulus of exocytosis in DRG neurons (Huang and
Neher, 1996) and for assessing neuronal health (data not shown). While we
cannot rule out a slight contribution of membrane stretch to our capacitance
measurements, the contribution would be relatively small based on theoretical
and empirical considerations and cannot account for the observed changes.
Even if the membrane were stretched through a TRPA1-dependent mecha-
nism, energetic constraints limit changes in membrane thickness (and thus
area) such that even the limiting stretch would produce a change in area of
1.85%, assuming no change in dielectric constant and constant volume of
the membrane beneath the pipette (Hamill and Martinac, 2001). No visible
cell swelling was observed over 10–15 min in the cell-attached patch configu-
ration used here (data not shown).
Statistical Analysis
If not stated otherwise, the nonparametric Mann-Whitney test was used for
single comparisons, and one-way ANOVA followed by Bonferroni’s multiple
comparison test was used for multiple comparisons (GraphPad Prism soft-ware). All values refer to mean ± SEM; n indicates the sample number,
p denotes the significance (*p < 0.05, **p < 0.01, ***p < 0.001) and refers to
the respective control (vehicle) in each experimental group if not noted other-
wise, and ns indicates ‘‘not significant.’’
SUPPLEMENTAL DATA
Supplemental data for this article include Supplemental Experimental Proce-
dures and five figures and can be found at http://www.cell.com/neuron/
supplemental/S0896-6273(09)00741-7.
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